Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.

類似資料

• Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
  著者:: de Wit, R., 等
  出版事項: (1997)
• Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
  著者:: de Wit, R., 等
  出版事項: (1998)
• Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.
  著者:: de Wit, R., 等
  出版事項: (1995)
• Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor
  著者:: Xavier, Rosana, 等
  出版事項: (2020)
• Torsion of an intraperitoneal undescended seminomatous testicular tumour
  著者:: McDermott, Frank Denis, 等
  出版事項: (2014)